A detailed history of Kcs Wealth Advisory transactions in Amgen Inc stock. As of the latest transaction made, Kcs Wealth Advisory holds 1,016 shares of AMGN stock, worth $320,588. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,016
Previous 1,780 42.92%
Holding current value
$320,588
Previous $395,000 30.89%
% of portfolio
0.12%
Previous 0.14%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$218.65 - $271.46 $167,048 - $207,395
-764 Reduced 42.92%
1,016 $273,000
Q2 2023

Jul 17, 2023

BUY
$214.27 - $253.37 $2,999 - $3,547
14 Added 0.79%
1,780 $395,000
Q1 2023

Apr 17, 2023

SELL
$225.79 - $275.2 $1,580 - $1,926
-7 Reduced 0.39%
1,766 $426,000
Q4 2022

Feb 07, 2023

SELL
$229.03 - $291.01 $1,374 - $1,746
-6 Reduced 0.34%
1,773 $465,000
Q3 2022

Oct 21, 2022

BUY
$224.46 - $253.15 $2,244 - $2,531
10 Added 0.57%
1,779 $401,000
Q1 2022

Apr 13, 2022

BUY
$219.27 - $242.57 $2,850 - $3,153
13 Added 0.74%
1,769 $428,000
Q4 2021

Jan 26, 2022

SELL
$198.88 - $227.6 $1,591 - $1,820
-8 Reduced 0.45%
1,756 $395,000
Q2 2021

Jul 27, 2021

SELL
$233.58 - $259.14 $233 - $259
-1 Reduced 0.06%
1,764 $430,000
Q1 2021

Apr 19, 2021

BUY
$221.91 - $258.6 $81,219 - $94,647
366 Added 26.16%
1,765 $439,000
Q4 2020

Jan 28, 2021

BUY
$216.38 - $257.67 $432 - $515
2 Added 0.14%
1,399 $322,000
Q3 2020

Oct 27, 2020

BUY
$234.65 - $260.95 $469 - $521
2 Added 0.14%
1,397 $355,000
Q2 2020

Jul 16, 2020

BUY
$197.81 - $242.74 $6,923 - $8,495
35 Added 2.57%
1,395 $329,000
Q1 2020

Apr 28, 2020

SELL
$182.24 - $241.7 $182 - $241
-1 Reduced 0.07%
1,360 $276,000
Q4 2019

Jan 15, 2020

BUY
$189.21 - $243.2 $4,162 - $5,350
22 Added 1.64%
1,361 $328,000
Q3 2019

Oct 29, 2019

BUY
$174.11 - $208.62 $4,700 - $5,632
27 Added 2.06%
1,339 $259,000
Q2 2019

Jul 29, 2019

SELL
$166.7 - $195.41 $4,000 - $4,689
-24 Reduced 1.8%
1,312 $242,000
Q1 2019

Apr 29, 2019

BUY
$180.87 - $203.88 $3,255 - $3,669
18 Added 1.37%
1,336 $254,000
Q4 2018

Jan 17, 2019

BUY
$178.4 - $208.25 $1,962 - $2,290
11 Added 0.84%
1,318 $257,000
Q3 2018

Nov 06, 2018

SELL
$185.29 - $208.89 $31,684 - $35,720
-171 Reduced 11.57%
1,307 $271,000
Q2 2018

Aug 07, 2018

SELL
$166.05 - $186.51 $5,313 - $5,968
-32 Reduced 2.12%
1,478 $273,000
Q1 2018

May 04, 2018

BUY
$169.43 - $198.0 $255,839 - $298,980
1,510 New
1,510 $257,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Kcs Wealth Advisory Portfolio

Follow Kcs Wealth Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcs Wealth Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Kcs Wealth Advisory with notifications on news.